K
Katarzyna Mitka
Publications - 14
Citations - 797
Katarzyna Mitka is an academic researcher. The author has contributed to research in topics: Indane & Betanin. The author has an hindex of 8, co-authored 14 publications receiving 719 citations.
Papers
More filters
Journal ArticleDOI
Oxidation of sulfides to sulfoxides. Part 2: Oxidation by hydrogen peroxide
TL;DR: In this article, the authors reviewed the oxidation of sulfides to sulfoxides by hydrogen peroxide and provided 120 references, 14 tables and 16 schemes and 6 figures, with a total of 6 figures.
Journal ArticleDOI
Oxidation of sulfides to sulfoxides. Part 1: Oxidation using halogen derivatives
Journal ArticleDOI
Minor betalains in fruits of Hylocereus species.
TL;DR: The peel contained a more complex pattern of betacyanins with apiofuranosyl moiety and the sinapoyl moiety attachment position in the structure of betACYanins was established for the first time.
Journal ArticleDOI
Novel arylsulfonamide derivatives with 5‑HT6/5-HT7 receptor antagonism targeting behavioral and psychological symptoms of dementia
Marcin Kołaczkowski,Monika Marcinkowska,Adam Bucki,Maciej Pawłowski,Katarzyna Mitka,Jolanta Jaśkowska,Piotr A. Kowalski,Grzegorz Kazek,Agata Siwek,Anna Wasik,Anna Wesołowska,Paweł Mierzejewski,Przemyslaw Bienkowski +12 more
TL;DR: Novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT(6/7/2A) and D2 receptors, without interacting with M1 receptors and hERG channels are obtained to target behavioral and psychological symptoms of dementia.
Journal ArticleDOI
New Arylpiperazines with Flexible versus Partly Constrained Linker as Serotonin 5‐HT1A/5‐HT7 Receptor Ligands
TL;DR: Within the o‐OMe‐PhP series, except for a small binding reduction for ligands containing the m‐xylyl moiety, there was no substantial change in the compounds' potency at both receptors, while for the THIQ derivatives a clear structure–activity relationship was visible only for the interaction of the compounds with the 5‐HT7 receptor, which strongly favored flexible analogs.